Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Metadata
Title
Prognosis and mortality of polymyositis and dermatomyositis patients
Authors
A. Airio
H. Kautiainen
M. Hakala
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-1164-z

Other articles of this Issue 2/2006

Clinical Rheumatology 2/2006 Go to the issue

Original Article

Predictive value of naitfold capillaroscopy in patients with Raynaud’s phenomenon

Original Article

Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients

Original Article

Association of systemic and thyroid autoimmune diseases

Erratum

Erratum to: Concurrent occurrence of Sweet’s syndrome and erythema nodosum: an overlap in the spectrum of reactive dermatoses

Original Article

Depression, attribution style and self-esteem in chronic fatigue syndrome and fibromyalgia patients: is there a link?

Original Article

Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits